First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
2020 ◽
Vol 130
◽
pp. 155-167
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 8177-8177
2010 ◽
Vol 76
(1)
◽
pp. 53-60
◽
2004 ◽
Vol 19
(2)
◽
pp. 109-113
2004 ◽
Vol 22
(14_suppl)
◽
pp. 8177-8177
Keyword(s):
2012 ◽
Vol 20
(11)
◽
pp. 2721-2727
◽